Apoptotic cell death in disease-Current understanding of the NCCD 2023

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Italian Institute for Genomic Medicine (IIGM)
  • Karolinska Institutet
  • Weill Cornell Medical College in Qatar
  • Icahn School of Medicine at Mount Sinai
  • University of Texas Southwestern Medical Center
  • Kiel University
  • University of Rome Tor Vergata
  • Department of Cellular and Molecular Medicine
  • Thomas Jefferson University
  • University of Campania Luigi Vanvitelli
  • University of Konstanz
  • Sunnybrook Research Institute
  • Hebrew University of Jerusalem
  • Weizmann Institute of Science
  • University of Massachusetts Medical School
  • Fox Chase Cancer Center
  • German Center for Neurodegenerative Diseases (DZNE)
  • Nazarbayev University School of Medicine
  • Louisiana State University Health Sciences Center
  • Friedrich-Alexander University Erlangen-Nürnberg
  • VIB-UGent Center for Inflammation Research
  • University of Connecticut
  • Roswell Park Comprehensive Cancer Center
  • Jill Roberts Institute for Research in Inflammatory Bowel Disease
  • IRCSS Regina Elena National Cancer Institute
  • University of Freiburg
  • National Institutes of Health (NIH)
  • Centro de Investigaciones Biologicas Margarita Salas
  • Université Paris-Saclay
  • University of Lausanne
  • Technical University of Denmark
  • University of Texas at Austin
  • Queen Mary University of London
  • University of Hawai'i at Mānoa
  • Graz University of Technology
  • Center for Autophagy
  • Duke University
  • Shanghai Jiao Tong University
  • Nankai University
  • Shenzhen Institute of Advanced Technology
  • Memorial Sloan-Kettering Cancer Center

Abstract

Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions. Here, the Nomenclature Committee on Cell Death (NCCD) gathered to critically summarize an abundant pre-clinical literature mechanistically linking the core apoptotic apparatus to organismal homeostasis in the context of disease.

Details

Original languageEnglish
Pages (from-to)1097-1154
Number of pages58
JournalCell death and differentiation
Volume30
Issue number5
Publication statusPublished - May 2023
Peer-reviewedYes

External IDs

PubMedCentral PMC10130819
Scopus 85153609153
ORCID /0000-0001-6874-0548/work/148143851
ORCID /0000-0001-6287-9725/work/148145950

Keywords

Sustainable Development Goals

Keywords

  • Animals, Humans, Apoptosis/genetics, Cell Death, Caspases/genetics, Carcinogenesis, Mammals/metabolism

Library keywords